Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes the gradual loss of motor neurons in the brain and spinal cord, leading to muscle weakness, paralysis, and ...

In the beginning, not even Hynek Wichterle's postdoc thought his idea to slow the progression of amyotrophic lateral ...

Amyotrophic Lateral Sclerosis Treatment Market Type Insights Sporadic ALS holds a significant market revenue share, driven by its increasing incidence and the growing aging population.

Stone will be joining Dane — whom she has been friends with "for a long time" — on the long-awaited third season of the HBO ...

Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to ...

Clene (NASDAQ: CLNN) , a late clinical-stage biopharma company developing treatments for neurodegenerative diseases, reported Q2 2025 results and sai ...

Answer ALS, in collaboration with ALS Therapy Development Institute (ALS TDI) and Augie's Quest, today announced plans to ...

Neurologist and Duke ALS Clinic Director Richard Bedlack “stitches strength” for his patients, showing the powers of hope.

A patient with ALS, who lost use of his hands, has become the first person in the world to control an iPad entirely by ...